Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial

Medicine and Dentistry

• Premature Labor 100%
• Progesterone 100%
• Placebo 50%
• Obstetrics 30%
• Medical Research 20%
• Program Evaluation 20%
• Adverse Event 10%
• Intention-to-Treat Analysis 10%
• Adverse Outcome 10%
• Brain Injury 10%
• Newborn Morbidity 10%
• Fibronectin 10%
• Second Trimester Pregnancy 10%
• Cervical Length Measurement 10%
• Fetus Death 10%
• Lung Dysplasia 10%
• Odds Ratio 10%
• Premature Fetus Membrane Rupture 10%
• Fencamfamin 10%
• Primary Outcome 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Premature Labor 100%
• Progesterone 100%
• Placebo 50%
• Adverse Event 10%
• Brain Injury 10%
• Lung Dysplasia 10%
• Adverse Outcome 10%
• Fibronectin 10%
• Fetus Death 10%
• Newborn Morbidity 10%
• Premature Fetus Membrane Rupture 10%
• Fencamfamin 10%